BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 23443212)

  • 1. S39, a novel Aurora B kinase inhibitor, shows potent antineoplastic activity in human Hela cervical cancer cell line.
    Li J; Lang Q; Zhang H; Huang Q; Yu L
    Biotechnol Lett; 2013 Jun; 35(6):853-60. PubMed ID: 23443212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A thienopyrimidine derivative induces growth inhibition and apoptosis in human cancer cell lines via inhibiting Aurora B kinase activity.
    Li J; Hu H; Lang Q; Zhang H; Huang Q; Wu Y; Yu L
    Eur J Med Chem; 2013 Jul; 65():151-7. PubMed ID: 23707920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dietary flavonoid luteolin inhibits Aurora B kinase activity and blocks proliferation of cancer cells.
    Xie F; Lang Q; Zhou M; Zhang H; Zhang Z; Zhang Y; Wan B; Huang Q; Yu L
    Eur J Pharm Sci; 2012 Aug; 46(5):388-96. PubMed ID: 22449725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivo.
    Arbitrario JP; Belmont BJ; Evanchik MJ; Flanagan WM; Fucini RV; Hansen SK; Harris SO; Hashash A; Hoch U; Hogan JN; Howlett AR; Jacobs JW; Lam JW; Ritchie SC; Romanowski MJ; Silverman JA; Stockett DE; Teague JN; Zimmerman KM; Taverna P
    Cancer Chemother Pharmacol; 2010 Mar; 65(4):707-17. PubMed ID: 19649632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo characterization of a benzofuran derivative, a potential anticancer agent, as a novel Aurora B kinase inhibitor.
    Xie F; Zhu H; Zhang H; Lang Q; Tang L; Huang Q; Yu L
    Eur J Med Chem; 2015 Jan; 89():310-9. PubMed ID: 25462247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dual Aurora kinase inhibitor ZM447439 prevents anaplastic thyroid cancer cell growth and tumorigenicity.
    Baldini E; Tuccilli C; Prinzi N; Sorrenti S; Antonelli A; Gnessi L; Catania A; Moretti C; Mocini R; Carbotta G; Morrone S; Persechino S; Redler A; De Antoni E; D' Armiento M; Ulisse S
    J Biol Regul Homeost Agents; 2013; 27(3):705-15. PubMed ID: 24152827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization and biological evaluation of 2-aminobenzothiazole derivatives as Aurora B kinase inhibitors.
    Lee E; An Y; Kwon J; Kim KI; Jeon R
    Bioorg Med Chem; 2017 Jul; 25(14):3614-3622. PubMed ID: 28529042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMG 900, pan-Aurora kinase inhibitor, preferentially inhibits the proliferation of breast cancer cell lines with dysfunctional p53.
    Kalous O; Conklin D; Desai AJ; Dering J; Goldstein J; Ginther C; Anderson L; Lu M; Kolarova T; Eckardt MA; Langerød A; Børresen-Dale AL; Slamon DJ; Finn RS
    Breast Cancer Res Treat; 2013 Oct; 141(3):397-408. PubMed ID: 24091768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trivalent dimethylarsenic compound induces histone H3 phosphorylation and abnormal localization of Aurora B kinase in HepG2 cells.
    Suzuki T; Miyazaki K; Kita K; Ochi T
    Toxicol Appl Pharmacol; 2009 Dec; 241(3):275-82. PubMed ID: 19716834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-Hydroxyflavone inhibits endogenous Aurora B and induces growth inhibition of cancer cell line.
    Lang Q; Zhang H; Li J; Xie F; Zhang Y; Wan B; Yu L
    Mol Biol Rep; 2010 Mar; 37(3):1577-83. PubMed ID: 19437133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new small-molecule Aurora B inhibitor shows antitumor activity in human cancer cell lines.
    Wu Y; Li J; Jiang C; Yang X; Cao L; Yu L
    Mol Biol Rep; 2015 Feb; 42(2):517-24. PubMed ID: 25348602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GSK1070916, a potent Aurora B/C kinase inhibitor with broad antitumor activity in tissue culture cells and human tumor xenograft models.
    Hardwicke MA; Oleykowski CA; Plant R; Wang J; Liao Q; Moss K; Newlander K; Adams JL; Dhanak D; Yang J; Lai Z; Sutton D; Patrick D
    Mol Cancer Ther; 2009 Jul; 8(7):1808-17. PubMed ID: 19567821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jadomycin B, an Aurora-B kinase inhibitor discovered through virtual screening.
    Fu DH; Jiang W; Zheng JT; Zhao GY; Li Y; Yi H; Li ZR; Jiang JD; Yang KQ; Wang Y; Si SY
    Mol Cancer Ther; 2008 Aug; 7(8):2386-93. PubMed ID: 18723485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells.
    D'Alise AM; Amabile G; Iovino M; Di Giorgio FP; Bartiromo M; Sessa F; Villa F; Musacchio A; Cortese R
    Mol Cancer Ther; 2008 May; 7(5):1140-9. PubMed ID: 18483302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Characterization of Derrone as an Aurora Kinase Inhibitor.
    Hoang NT; Phuong TT; Nguyen TT; Tran YT; Nguyen AT; Nguyen TL; Bui KT
    Biol Pharm Bull; 2016 Jun; 39(6):935-45. PubMed ID: 26983907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of 4-aminoquinazoline--urea derivatives as Aurora kinase inhibitors with antiproliferative activity.
    Cai J; Li L; Hong KH; Wu X; Chen J; Wang P; Cao M; Zong X; Ji M
    Bioorg Med Chem; 2014 Nov; 22(21):5813-23. PubMed ID: 25270403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The selective Aurora B kinase inhibitor AZD1152 as a novel treatment for hepatocellular carcinoma.
    Aihara A; Tanaka S; Yasen M; Matsumura S; Mitsunori Y; Murakata A; Noguchi N; Kudo A; Nakamura N; Ito K; Arii S
    J Hepatol; 2010 Jan; 52(1):63-71. PubMed ID: 19913935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting aurora kinases with danusertib (PHA-739358) inhibits growth of liver metastases from gastroenteropancreatic neuroendocrine tumors in an orthotopic xenograft model.
    Fraedrich K; Schrader J; Ittrich H; Keller G; Gontarewicz A; Matzat V; Kromminga A; Pace A; Moll J; Bläker M; Lohse AW; Hörsch D; Brümmendorf TH; Benten D
    Clin Cancer Res; 2012 Sep; 18(17):4621-32. PubMed ID: 22753592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validating Aurora B as an anti-cancer drug target.
    Girdler F; Gascoigne KE; Eyers PA; Hartmuth S; Crafter C; Foote KM; Keen NJ; Taylor SS
    J Cell Sci; 2006 Sep; 119(Pt 17):3664-75. PubMed ID: 16912073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of GSK1070916, a potent and selective inhibitor of Aurora B/C kinase.
    Adams ND; Adams JL; Burgess JL; Chaudhari AM; Copeland RA; Donatelli CA; Drewry DH; Fisher KE; Hamajima T; Hardwicke MA; Huffman WF; Koretke-Brown KK; Lai ZV; McDonald OB; Nakamura H; Newlander KA; Oleykowski CA; Parrish CA; Patrick DR; Plant R; Sarpong MA; Sasaki K; Schmidt SJ; Silva DJ; Sutton D; Tang J; Thompson CS; Tummino PJ; Wang JC; Xiang H; Yang J; Dhanak D
    J Med Chem; 2010 May; 53(10):3973-4001. PubMed ID: 20420387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.